Your shopping cart is currently empty

FGI-106 is a potent, broad-spectrum inhibitor demonstrating activity against various viruses, including Ebola, Rift Valley Fever, and Dengue Fever, exhibiting EC50 values of 100 nM, 800 nM, and 400-900 nM, respectively. Furthermore, it effectively inhibits non-hemorrhagic fever viruses such as HCV and HIV-1, with EC50s of 200 nM and 150 nM, respectively.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $2,420 | 1-2 weeks | 1-2 weeks | |
| 50 mg | $3,180 | 1-2 weeks | 1-2 weeks | |
| 100 mg | $4,300 | 1-2 weeks | 1-2 weeks |
| Description | FGI-106 is a potent, broad-spectrum inhibitor demonstrating activity against various viruses, including Ebola, Rift Valley Fever, and Dengue Fever, exhibiting EC50 values of 100 nM, 800 nM, and 400-900 nM, respectively. Furthermore, it effectively inhibits non-hemorrhagic fever viruses such as HCV and HIV-1, with EC50s of 200 nM and 150 nM, respectively. |
| Targets&IC50 | DENV: 400-900 nM , HIV-1:150 nM , EBOV:(EC50)100 nM , HCV: 200 nM , Rift Valley virus: 800 nM |
| In vitro | In cell-based assays, FGI-106 effectively inhibits replication across diverse virus families, encompassing both positive and negative-strand RNA viruses. A concentration of 2 μM FGI-106 resulted in a significant four-log decrease in infectious viral titers compared to matched controls. Moreover, the effective concentration required to achieve 90% inhibition of viral-induced cytotoxicity in host cells (Vero E6 cells) is estimated to be 0.6 μM. |
| In vivo | FGI-106 (0.1-5 mg/kg; intraperitoneal injection; treatments on days 2 and 5; C57BL/6 or BALB/c mice) reduces mortality from Zaire EBOV in a dose-dependent manner. |
| Molecular Weight | 458.64 |
| Formula | C28H38N6 |
| Cas No. | 501081-38-5 |
| Smiles | N(CCCN(C)C)C1=C2C(C3=C(C=4C(C=C3)=C(NCCCN(C)C)C=C(C)N4)C=C2)=NC(C)=C1 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.